Cell Size Inheritance and Innate Immune Memory
About This Grant
Project Summary Excessive cell growth contributes to senescence and is a hallmark of aging. In the innate immune system, monocyte distribution width (the standard deviation of the monocyte mean volume) has been proposed as a diagnostic marker for severe infection and early sepsis detection. Increased cell size is also associated with an exhaustion-like memory state. While both senescence and immune exhaustion can be pathogenic, they differ in their reversibility: senescence is characterized by an irreversible cell cycle arrest, whereas exhaustion in innate immune cells retains cell cycle activity and proliferative potential. It remains unclear how enlarged immune cells in an exhausted state can maintain immune surveillance without transitioning into senescence. Our unpublished work identifies a pathway regulated by the endocytic protein FBP17 that increases the cell size setpoint without inducing senescence. FBP17-deficient mast cells and macrophages remain proliferative despite their enlarged size. Similarly, exhausted monocytes subjected to repeated LPS stimulation in vitro exhibit both increased cell size and reduced FBP17 expression. In vivo, we also made a novel observation that monocytes isolated from aged mice with exhaustion-like memory signatures display reduced levels of FBP17, which strongly correlate with their enlarged size compared to monocytes from young mice. These findings suggest that cell enlargement does not inherently lead to proliferative arrest and that increases in cell size may be reversible. Using a single-cell microchannel system to monitor real-time cell growth and quantify size homeostasis, we further discovered that FBP17 knockdown cells increase their sizes through an "adder" growth mechanism. In this model, cells do not divide upon reaching a specific size threshold; instead, they add a fixed volume each generation. This behavior implies a form of transgenerational memory that depends on lineage age. We hypothesize that FBP17, along with the adder-based enlargement mechanism, plays a key role in enabling immune cells to grow without entering senescence. We aim to investigate how size increment is regulated via growth rate modulation, the molecular basis of intergenerational memory transmission, and whether this mechanism contributes to immune exhaustion memory. Understanding this non-canonical pathway of cell size regulation will offer novel strategies for reversing aging-associated cellular changes.
Grant Summary
Cell Size Inheritance and Innate Immune Memory is a NIA - National Institute on Aging grant providing up to $681K for university, nonprofit, healthcare org. Applications are due 2031-04-30 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $681K
2031-04-30
- 1Confirm your organization is eligible for Cell Size Inheritance and Innate Immune Memory from NIA - National Institute on Aging, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIA - National Institute on Aging before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIA - National Institute on Aging's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Cell Size Inheritance and Innate Immune Memory: Frequently Asked Questions
Who is eligible for the Cell Size Inheritance and Innate Immune Memory?
Cell Size Inheritance and Innate Immune Memory is offered by NIA - National Institute on Aging and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Cell Size Inheritance and Innate Immune Memory provide?
Cell Size Inheritance and Innate Immune Memory provides up to $681K per award from NIA - National Institute on Aging. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Cell Size Inheritance and Innate Immune Memory deadline?
Applications for Cell Size Inheritance and Innate Immune Memory are due 2031-04-30 (open). Because deadlines can change, verify the date with the funder, NIA - National Institute on Aging, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Cell Size Inheritance and Innate Immune Memory?
To apply for Cell Size Inheritance and Innate Immune Memory, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIA - National Institute on Aging.